Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Renato Capelj

EXCLUSIVE: How Avicanna Is Advancing Plant-Derived, Cannabinoid-Based Products

Regulation is among the factors inhibiting the flow of capital to cannabis innovation.

Institutions are afraid to invest, and “big pharma is not coming in as we would like to see happen.”

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.